VALLEY FORGE, Pa.--(BUSINESS WIRE)--May 10,
2004--AmerisourceBergen Corporation (NYSE:ABC) today acquired
Imedex(R), Inc., a privately held, accredited provider of physician
continuing medical education (CME) for approximately $16 million in
cash. Imedex is headquartered in Alpharetta, Georgia, and had calendar
2003 revenues of approximately $11 million.
"Imedex's outstanding array of physician education services
continues our commitment to add incremental services that support
manufacturers and healthcare providers along the pharmaceutical supply
channel," said R. David Yost, AmerisourceBergen Chief Executive
Officer. "Imedex, which will become an independent part of the
AmerisourceBergen Specialty Group, brings an attractive combination of
highly regarded proprietary programs and client services for
physicians, international scope and solid growth."
"As a part of AmerisourceBergen, we expect to accelerate our
offerings under our motto of 'education is the best medicine,'" said
Stefan Terwindt, Imedex President. "Our medical meetings, symposia and
other activities will continue to focus on medical education in the
rapidly advancing, complex and knowledge-intensive areas of oncology,
infectious diseases, psychiatry, gastroenterology, urology,
endocrinology, neurology and cardiology."
About AmerisourceBergen
AmerisourceBergen (NYSE:ABC) is one of the largest pharmaceutical
services companies in the United States. Servicing both pharmaceutical
manufacturers and healthcare providers in the pharmaceutical supply
channel, the Company provides drug distribution and related services
designed to reduce costs and improve patient outcomes.
AmerisourceBergen's service solutions range from pharmacy automation,
bedside medication safety systems, and pharmaceutical packaging to
pharmacy services for skilled nursing and assisted living facilities,
reimbursement and pharmaceutical consulting services, and physician
education. With more than $47 billion in annualized operating revenue,
AmerisourceBergen is headquartered in Valley Forge, PA, and employs
more than 14,000 people. AmerisourceBergen is ranked #22 on the
Fortune 500 list. For more information, go to
www.amerisourcebergen.com.
About Imedex(R), Inc.
Based in Alpharetta, Georgia, USA, Imedex(R), Inc.
(www.imedex.com) is an industry leader in providing accredited medical
education services. With 20 years experience in medical education,
Imedex concentrates on developing proprietary independent CME programs
worldwide and collaborates with medical associations and health care
companies to produce a full range of medical education products. With
innovative and focused scientific programs, Imedex continually exceeds
the expectations of thousands of physicians each year.
Imedex has extensive relationships with leading healthcare
professionals and opinion leaders in many fields of medicine. Imedex
provides a fully staffed medical resource department as well as
in-house business development, project management, marketing and
graphic and web-design services. Founded in 1985 in The Netherlands,
Imedex established its US-based operations in 1987.
FORWARD-LOOKING STATEMENTS
This news release may contain certain "forward-looking statements"
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. These statements
are based on management's current expectations and are subject to
uncertainty and changes in circumstances. Actual results may vary
materially from the expectations contained in the forward-looking
statements. Forward-looking statements may include statements
addressing future financial and operating results of AmerisourceBergen
and the benefits and other aspects of the 2001 merger between
AmeriSource Health Corporation and Bergen Brunswig Corporation.
The following factors, among others, could cause actual results to
differ materially from those described in any forward-looking
statements: competitive pressures; the loss of one or more key
customer relationships; customer insolvencies; changes in customer
mix; changes in pharmaceutical manufacturers' pricing and distribution
policies; regulatory changes; changes in U.S. government policies;
failure to integrate the businesses of AmeriSource and Bergen Brunswig
successfully; failure to obtain and retain expected synergies from the
merger of AmeriSource and Bergen Brunswig; and other economic,
business, competitive, regulatory and/or operational factors affecting
the business of AmerisourceBergen generally.
More detailed information about these factors is set forth in
AmerisourceBergen's filings with the Securities and Exchange
Commission, including its Annual Report on Form 10-K for fiscal 2003.
AmerisourceBergen is under no obligation to (and expressly
disclaims any such obligation to) update or alter any forward looking
statements whether as a result of new information, future events or
otherwise.
CONTACT: AmerisourceBergen, Valley Forge
Michael N. Kilpatric, 610-727-7118
mkilpatric@amerisourcebergen.com
SOURCE: AmerisourceBergen